Tech Company Financing Transactions
Elypta Funding Round
On 6/20/2022, Elypta raised $21 million in Series A funding from Bonnier Ventures, Chalmers Ventures and Hillclimber.
Transaction Overview
Company Name
Announced On
6/20/2022
Transaction Type
Venture Equity
Amount
$21,000,000
Round
Series A
Investors
Bonnier Ventures (Lead Investor) (Sofia Hasselberg)
Proceeds Purpose
The company will use the capital to develop and validate blood and urine tests for Multi-Cancer Early Detection (MCED) in adults with no symptoms of cancer and for detection of recurrence in kidney cancer patients.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Karolinska Institute Nanna Svartz väg 4
Solna, 17165
Sweden
Solna, 17165
Sweden
Phone
Website
Email Address
Overview
Elypta is a Swedish molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome -- system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer noninvasively. Elypta is advancing a broad clinical program across different cancers with the first indication expected to be early detection of recurrence in renal cell carcinoma.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 6/20/2022: Artio Medical venture capital transaction
Next: 6/20/2022: MicroTransponder venture capital transaction
Share this article
News on VC Transactions
We record every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs